Autres langues CRISPR Therapeutics AG

Actions

CRSP

CH0334081137

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 06/06/2024			Varia. 5j.	Varia. 1 janv.
59,96 ^USD	+0,40 %		+11,35 %	-4,22 %

23/05	CRISPR Therapeutics nomme Naimish Patel au poste de Chief Medical Officer et promeut Julianne Bruno au poste de Chief Operating Officer	MT
23/05	CRISPR Therapeutics annonce des changements de direction	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

CRISPR Therapeutics to Participate in Upcoming Investor Conferences	29/05
CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer	23/05
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments	23/05
CRISPR Therapeutics Announces Executive Changes	23/05
CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference	09/05
CRISPR Therapeutics AG Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Earnings Flash (CRSP) CRISPR THERAPEUTICS AG Reports Q1 Revenue $504,000	08/05
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results	08/05
CRISPR Therapeutics : ASGCT 2024 Oral Presentation	08/05
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach	08/05
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing in Vivo Gene Editing Approach	08/05
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene and Cell Therapy 2024 Annual Meeting	23/04
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting	22/04
Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing	17/04
Harvard University: How to realize immense promise of gene editing	17/04
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference	03/04
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting	01/04
Recent Appellate Decision Overturns Revocations Of Broad Institute CRISPR-Cas9 Patents	26/03
CRISPR Therapeutics Proposes New Appointment to the Board of Directors	13/03
CRISPR Therapeutics Swings to Q4 Profit, Revenue Increases	21/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues CRISPR Therapeutics AG

Actions

CRSP

CH0334081137

Autres langues

Filtres